Back to calendar
Kymera Therapeutics, Inc. (KYMR) Earnings
KYMR reports earnings on Wednesday, August 5, 2026
earnings report
August 5, 2026
Q2 2026
Est. EPS: $-1.21
Actual EPS: $-0.62
EPS surprise: 12.99%
Company overview
Market Cap$8.8B
PriceUSD 105.88
EPS (TTM)-3.24
52-week high130.05
52-week low36.65
SectorHealth Technology
IndustryBiotechnology
Employees238